AZ licenses Dizal’s lung cancer drug in $1.5bn deal
AstraZeneca has struck a $1.5bn agreement with Shanghai-based Dizal Pharmaceutical for global rights to sunvozertinib, an oral lung cancer therapy already approved in China and…
-
-
Patient-Centred Brain–Gut Therapy Outcomes – EMJ
PATIENT priorities for treatment outcomes following brain–gut behavioural therapy (BGBT) differ from outcomes traditionally prioritised in clinical trials, such as anxiety and depression, according to a new US study highlighting the importance of…
-
Cosmetic procedures may become addictive for some women, researchers say
A screen time app that lets friends cut their phone use together has won the £15,000 top prize in a women-led startup competition. Snitch, led…
-
Interview: Christopher Cogle – European Medical Journal
Your work spans clinical oncology, stem cell biology, public health leadership, and healthcare policy. How have those different domains influenced the way you think about…
-
Our latest Hepatology Journal – European Medical Journal
Liver medicine is at a turning point. To deliver cutting-edge patient care and lead the field, healthcare professionals need a definitive guide to the clinical…
-
Altered Brain Health in Soccer Players: AAIC 2026
DATA presented at AAIC 2026 showed that former elite soccer players had higher rates of depression and anxiety and lower grey matter volume than healthy…
-
Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
Roche subsidiary Genentech has signed a global drug discovery and licensing agreement with UK biotech Astex Pharmaceuticals worth up to $490 million. Roche will pay…
-
Prison Leprosy Screening Detects Hidden Cases
LEPROSY screening identified undiagnosed multibacillary disease and disability among incarcerated men in northeastern Brazil. Leprosy Screening Reveals Missed Cases Researchers conducted an observational cross sectional…
-
Breast cancer rising rapidly in Asian American women, study finds
Breast cancer rates have risen rapidly among Asian American women over the past two decades, with some of the steepest increases among women under 50,…
-
Elysium Health Pilot Study Links NAD+ Supplementation to Menopause Symptom Relief
Elysium Health, the longevity science company, has published research in Frontiers in Aging suggesting a potential connection between NAD+ metabolism, estrogen balance, and menopausal symptoms….
